Skip to main content

Table 1 Samples for technical validation of RLEP qPCR and 16S rRNA RT qPCR

From: Development of a combined RLEP/16S rRNA (RT) qPCR assay for the detection of viable M. leprae from nasal swab samples

Purpose

Sample type (No.)

Obtained from

Origin

“Must detect RLEP/16S rRNA (DNA)” samples

Nasal swab sample (4)a

2 sequencing confirmed MB leprosy patients

Togo

PCR standard (1 per RLEP and 16S rRNA qPCR)

Cloned RLEP/16S rRNA plasmids with known copy numbers

GenExpress, Berlin, Germany

“Must not detect RLEP/16S rRNA (DNA)” samples

Nasal swab sample (14)a

7 endemic controls (healthy individuals)

Togo

Nasal swab sample (10)a

5 occupational contacts to untreated (MB) leprosy patients

Munich, DITMb medical staff

Nasal swab sample (6)a

3 non-exposed healthy controls

Munich, DITMb laboratory staff

Swab sample (5)a

5 PCR confirmed Buruli ulcer patients

Ghana [24]

Fine needle aspirate (12)a

11 PCR confirmed Buruli ulcer patients

Ghana [24]

Swab sample (1)a

3 Patients with PCR confirmed cutaneaous leishmaniasis

Munich, accredited diagnostic laboratories of DITMb

Punch biopsy sample (2)a

Mycobacterial culture (13)a

M. abscessus, M. africanum, M. avium, M. bovis, M. fortuitum, M. gordonae, M. intracellulare, M. kansasii, M. malmoense, M. marinum, M. microti, M. tuberculosis, M. xenopi

National Reference Center for Mycobacteria, Borstel, Germany

Bacterial culture (5)a

Microbial flora colonizing human skin or nasal mucosa: Propionibacterium acnes, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes and Escherichia coli

Max von Pettenkofer-Institute, Ludwig-Maximilians-University, Munich, Germany

  1. a DNA extracts (additional file – protocol 1)
  2. b DITM, Department of Infectious Diseases and Tropical Medicine (accredited according to DIN EN ISO 15189)